3191 results for «438»

Filter By

3191 results

Redefining standards: TAVI in the era of lifetime management, beyond high-risk patients

29 Sep 2025 – From PCR Gulf Valves 2025

Discover a selection of cases showcasing the key features of the Navitor Valve System and its clinical applications. This session explores auxiliary access, the use of Navitor in alternative access and complex PCI, its performance in challenging peripheral anatomies, and innovative outcomes with the Vantage 30D...

Redefining standards: TAVI in the era of lifetime management, beyond high-risk patients

Clinical cases

29 Sep 2025 – From PCR Gulf Valves 2025

This session presents challenging clinical cases focusing on post-TAVI paravalvular leakage and the percutaneous closure of paravalvular leaks following surgically implanted Intuity valves. Gain valuable insights into complex management strategies and procedural techniques addressing these complications.

Myval transcatheter heart valve series - Align for the future with novel design, data and daily clinical experience

29 Sep 2025 – From PCR Gulf Valves 2025

Join this comprehensive session to explore the Myval transcatheter heart valve series, featuring the latest clinical updates from two large randomized controlled trials—Landmark and Compare TAVI. Learn from real-world experiences, including recorded cases, and understand how these innovations translate to complex patient demographics in daily TAVI...

Myval transcatheter heart valve series - Align for the future with novel design, data and daily clinical experience

Mitral transcatheter edge-to-edge repair - LIVE Case

29 Sep 2025 – From PCR Gulf Valves 2025

A 65-year-old female with a history of atrial fibrillation, LAD PCI (2016), ICD implantation (2016), stroke, and insulin-dependent DM, presented with symptomatic severe secondary mitral regurgitation and poor left ventricular function (LVEF 20%). A single MitraClip was implanted under general anesthesia and TEE guidance.

LIVE Educational Case...

Mitral transcatheter edge-to-edge repair - LIVE Case

Tricuspid valve TEER workshop

29 Sep 2025 – From PCR Gulf Valves 2025

This workshop provides a comprehensive understanding of tricuspid valve anatomy, echocardiographic screening, and procedural guidance essential for successful tricuspid TEER. Learn to distinguish suitable candidates and gain hands-on experience with intra-procedural echocardiography techniques.

EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

04 Nov 2021

Elad Asher reviews the EROSION III trial, presented by Haibo Jia, which studied whether OCT guidance compared with angiographic guidance only is associated with lower stent rate implantation during pPCI in STEMI patients with non-obstructive stenosis.

Elad Asher

Author

Elad Asher
EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

Top Interventional Trials presented at ACC.21

07 Jun 2021

Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21

Author

Ali Nazmi Calik
Top Interventional Trials presented at ACC.21

A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial

03 Apr 2026

Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...

John Davies

Author

John Davies
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sarosh Khan

Author

Sarosh Khan
ORBITA-CTO: Chronic total occlusion PCI in stable angina

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?